Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Some issues concerning transdermal nitroglycerin patches.

J M Atkins

    American Heart Journal
    |July 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Transdermal nitroglycerin patches provide therapeutic benefits for 20-26 hours, improving exercise tolerance. Higher doses may enhance effectiveness, but more research is needed for long-term use.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Role of insulin receptor substrate-2 in interleukin-9-dependent proliferation.

    FEBS letters·2000
    Same author

    Developing shared learning in multiprofessional health care education: for whose benefit?

    Nurse education today·1997
    Same author

    The physician's role in minimizing prehospital delay in patients at high risk for acute myocardial infarction: recommendations from the National Heart Attack Alert Program. Working Group on Educational Strategies To Prevent Prehospital Delay in Patients at High Risk for Acute Myocardial Infarction.

    Annals of internal medicine·1997
    Same author

    Role of emergency medical services.

    Heart & lung : the journal of critical care·1991
    Same author

    Effect of varying drop size on the efficacy and safety of a topical beta blocker.

    Annals of ophthalmology·1989
    Same author

    Recent changes in management of acute myocardial infarction: implications for emergency care physicians.

    Journal of the American College of Cardiology·1988
    Same journal

    Stratified Medicine with Eplerenone for Myocardial Infarction or Injury and No obstructive Coronary Arteries: A Registry-Based Basket Trial.

    American heart journal·2026
    Same journal

    Revised Lipid-Lowering Therapy Guidelines in a Nationally Representative Sample.

    American heart journal·2026
    Same journal

    Cardiometabolic Health of Low- and Higher-Income Adults in the United States, 2009-2023.

    American heart journal·2026
    Same journal

    Moving Beyond Technical Capability to Regulatory Integration for Digital Health Technology Devices-Brief Communication from the Cardiovascular Sciences Research Consortium.

    American heart journal·2026
    Same journal

    THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

    American heart journal·2026
    Same journal

    DOAC Score Among Patients Receiving Vitamin K Antagonists.

    American heart journal·2026
    See all related articles

    Area of Science:

    • Cardiovascular Pharmacology
    • Exercise Physiology

    Background:

    • Transdermal nitroglycerin is utilized for managing cardiovascular conditions.
    • Understanding its duration of action and efficacy is crucial for patient care.

    Purpose of the Study:

    • To evaluate the duration of action of transdermal nitroglycerin.
    • To assess the dose-response relationship and comparative efficacy.

    Main Methods:

    • Exercise testing was employed to measure the duration of action.
    • Comparative studies assessed efficacy against other vasodilators.

    Main Results:

    • Transdermal nitroglycerin demonstrated a duration of action between 20 and 26 hours.
    • Increased exercise time was observed at 24 hours in most patients, with higher doses yielding greater improvements.

    Related Experiment Videos

  • Comparative studies indicated similar efficacy to isosorbide dinitrate and nifedipine.

    • Conclusions:

    • Transdermal nitroglycerin patches are an effective therapeutic option.
    • Titration to higher doses may be beneficial.
    • Further chronic use studies are necessary to confirm long-term efficacy and safety.